LivaNova Plc (LIVN)
77.14
+2.34
(+3.13%)
USD |
NASDAQ |
Jun 09, 16:00
77.14
0.00 (0.00%)
After-Hours: 20:00
LivaNova EPS Diluted (Quarterly) : 0.3985 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Smith & Nephew plc | -- |
| NovoCure Ltd. | -0.6232 |
| AstraZeneca PLC | 0.9849 |
| Axogen, Inc. | -0.3796 |
| Tandem Diabetes Care, Inc. | -0.2982 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 22.29M |
| Revenue (Quarterly) | 362.26M |
| Total Expenses (Quarterly) | 339.96M |
| Enterprise Value | 3.910B |
| Gross Profit Margin (Quarterly) | 67.59% |
| Profit Margin (Quarterly) | 6.15% |
| Earnings Yield | 2.51% |
| Operating Earnings Yield | 4.98% |
| Normalized Earnings Yield | 3.794 |